Mergon Group has announced its acquisition of Inmo Tech Limited, a specialist manufacturer of precision injection-moulded components for the healthcare and medical device sectors. The move is set to strengthen Mergon’s healthcare capabilities and support its long-term growth ambitions.
Inmo Tech offers injection moulding expertise, an established manufacturing facility and a highly experienced team. As part of the Mergon Group, Inmo Tech will benefit from its wider engineering, automation, product development, project management and global manufacturing capabilities.
“We are delighted to welcome Inmo Tech and its employees to Mergon Group,” said Stéphane Maravel, CEO of Mergon Group. “Inmo Tech has built a strong reputation for specialist injection moulding in healthcare, supported by deep technical knowledge and a committed team. The business is an excellent strategic fit for Mergon. Together, we can build on its existing strengths, support its customers and create new growth opportunities.”
Brendan Cunningham, General Manager of Inmo Tech, added, “Joining Mergon Group is an important new chapter for Inmo Tech. Mergon shares our commitment to customers, quality and technical excellence. Its scale, resources and international experience will support the continued development of the business while providing a strong home for our employees and customers.”
About Mergon
Mergon is an engineering-led, global manufacturing group that boasts operations in Ireland, USA, the Czech Republic, the UK and Mexico. The company is trusted by healthcare leaders including Abbott, Beckman Coulter and Pfizer.
